Cargando…
ACE2: At the crossroad of COVID-19 and lung cancer
Upregulation of Angiotensin Converting Enzyme-2 (ACE2) was frequently observed in patients with lung cancer. Interestingly, our recent study revealed that the same ACE2 receptor was also strongly upregulated in lungs during SARS-CoV2 infection. Therefore, it is possible that the upregulated expressi...
Autores principales: | Gottschalk, Gunnar, Knox, Konstance, Roy, Avik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946539/ https://www.ncbi.nlm.nih.gov/pubmed/33723522 http://dx.doi.org/10.1016/j.genrep.2021.101077 |
Ejemplares similares
-
Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases
por: Gottschalk, Carl Gunnar, et al.
Publicado: (2023) -
Correction: Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases
por: Gottschalk, Carl Gunnar, et al.
Publicado: (2023) -
SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
por: Fenizia, Claudio, et al.
Publicado: (2021) -
Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2023) -
Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad
por: Sparaneo, Angelo, et al.
Publicado: (2016)